ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer? - Sato T; Hagerty BL; Wu R; Ishikawa T; Takabe K (Annals of surgical oncology, 2025)